Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568087

Apexbio Technology LLC URIC-ACID-SODIUM-200MG
SDP

Catalog No. 5000568087
Encompass_Preferred

Uric acid sodium (CAS No 1198-77-2) is a compound commonly studied in the context of biomedical research particularly focusing on its role as a marker and potential modulator in metabolic and renal pathways Originating from the breakdown of purine nucleotides uric acid sodium affects inflammation and oxidative stress It is actively researched for its mechanism of action involving the inhibition of xanthine oxidase influencing pathways linked to gout and hyperuricemia Typical in vitro activities are observed in the nanomolar to low micromolar range Applications often include use in various cell models to study antioxidant properties in animal studies for evaluating impacts on kidney function and in drug screening processes for novel therapeutic agents targeting uric acid-related disorders Experimental concentrations typically depend on the specific research design

Catalog No. 50-005-68087 Supplier Apexbio Technology LLC Supplier No. A9998200
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Uric acid sodium (CAS No 1198-77-2) is a compound commonly studied in the context of biomedical research particularly focusing on its role as a marker and potential modulator in metabolic and renal pathways Originating from the breakdown of purine nucleotides uric acid sodium affects inflammation and oxidative stress It is actively researched for its mechanism of action involving the inhibition of xanthine oxidase influencing pathways linked to gout and hyperuricemia Typical in vitro activities are observed in the nanomolar to low micromolar range Applications often include use in various cell models to study antioxidant properties in animal studies for evaluating impacts on kidney function and in drug screening processes for novel therapeutic agents targeting uric acid-related disorders Experimental concentrations typically depend on the specific research design

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.